Elephas, a private company developing an oncology imaging diagnostics platform, has raised $55 million in Series C funding. The funding round was led by Venture Investors Health Fund and the State of Wisconsin Investment Board, with participation from other investors including Northpond Ventures and ARCH Ventures. Elephas aims to use the funding to advance its live tumor imaging diagnostic platform, which uses metabolic imaging and live patient biopsies to predict response to immunotherapy. The company is conducting observational clinical trials to demonstrate the correlation between a patient’s clinical response to immunotherapy and data obtained from the Elephas platform.
Elephas Raises $55M: Fueling Future Growth with Series C
Latest from Blog
Ark Labs Secures $25 Million Pre-Seed Investment from Tim Draper
TLDR: Ark Labs raises $2.5 million in pre-seed funding round led by Tim Draper. The startup aims to simplify Bitcoin payments for everyday use through the Ark protocol. Ark Labs, a Bitcoin
Kazakh-US Venture Fund Boosts Kazakhstan as Clinical Trials Hub
TLDR: FutureMed Ventures KZ, a Kazakh-American venture fund, aims to position Kazakhstan as a destination for clinical trials. The fund invests in brain tissue regeneration technology for severe ischemic strokes and plans
Hardware as a Service: The Future of Venture Capital Investing
TLDR: Hardware as a Service (HaaS) is emerging as the next big trend in venture capital, offering hardware solutions on a subscription basis. Israel is emerging as a key player in the
Stealthy VC Acquiring Prime SF Property Launches Restaurant Startup Hub
TLDR: VC Neil Mehta is acquiring properties on San Francisco’s Fillmore Street. He plans to create an innovative dining and shopping experience by launching a “Y Combinator for restaurants.” Neil Mehta, a
Shaping the Future: Top 4 Venture Capital Climate Companies
TLDR: Climate tech funding declined in Q2 2024, with fewer large deals and no new unicorns. Top venture capital climate companies like SOSV, Global Brain, Lowercarbon Capital, and Breakthrough Energy Ventures are